[GA10-02] Memantine in Alzheimer’s disease: Results of the unpublished studies IE2101 and MEM-MD-22 as well as unpublished responder analyses

Project no.:
GA10-02

Report type:
Working paper

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Head and nerves

02.08.2010

IQWiG supplements benefit assessment with previously unpublished studies

Press release

Accompanying information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealth.org.

Executive summary of the working paper: Memantine in Alzheimer’s disease: Results of the unpublished studies IE2101 and MEM-MD-22 as well as unpublished responder analyses

EN, PDF, 54 kB, PDF

published on Aug 2, 2010
Working paper: Memantine in Alzheimer’s disease: Results of the unpublished studies IE2101 and MEM-MD-22 as well as unpublished responder analyses

DE, PDF, 1 MB, PDF

published on Feb 2, 2010

Project no.	Title	Status
A05-19C	Memantine in Alzheimer's disease	Commission completed